Literature DB >> 23205105

Comparison of L1 expression and secretion in glioblastoma and neuroblastoma cells.

Weijiang Zhao1.   

Abstract

The expression of cell adhesion molecule L1 has been identified in a vast spectrum of tumors; however, its expression pattern with regard to tumor type is rarely discussed. In the present study, we studied L1 levels in human glioblastomas and neuroblastomas, and compared the expression and secretion of L1 in human glioblastoma U87-MG and neuroblastoma SK-N-SH cells. Immunofluorescence staining revealed different grades of L1 staining in human glioblastoma and neuroblastoma samples. In U87-MG cells, full-length L1 was weakly detected in cell lysates (CLs), while greater levels of abundant soluble L1 were confined in conditioned culture medium (CCM). In contrast, higher levels of full-length L1 were confined in SK-N-SH CLs, while almost no soluble forms of L1 were detected in CCM. Our data indicates various expression patterns of L1 in U87-MG and SK-N-SH cells, which may underlie the different malignancies of the two neural tumor types and further stress the importance of soluble L1-mediated signaling pathways in cell malignancy.

Entities:  

Year:  2012        PMID: 23205105      PMCID: PMC3506679          DOI: 10.3892/ol.2012.787

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  24 in total

1.  Neuregulin-1 (Nrg1) is mainly expressed in rat pituitary gonadotroph cells and possibly regulates prolactin (PRL) secretion in a juxtacrine manner.

Authors:  W Zhao; S-G Ren
Journal:  J Neuroendocrinol       Date:  2011-12       Impact factor: 3.627

Review 2.  L1CAM malfunction in the nervous system and human carcinomas.

Authors:  Michael K E Schäfer; Peter Altevogt
Journal:  Cell Mol Life Sci       Date:  2010-03-17       Impact factor: 9.261

3.  [Endogenous neuregulin-1 expression in the anterior pituitary of female Wistar-Furth rats during the estrous cycle].

Authors:  Wei-jiang Zhao; Song-guang Ren
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2011-06

Review 4.  L1 cell adhesion molecule (L1CAM) in invasive tumors.

Authors:  Shani Raveh; Nancy Gavert; Avri Ben-Ze'ev
Journal:  Cancer Lett       Date:  2009-01-13       Impact factor: 8.679

5.  L1 is associated with favorable outcome in neuroblastomas in contrast to adult tumors.

Authors:  Robin Wachowiak; Henning C Fiegel; Jussuf T Kaifi; Alexander Quaas; Annika Krickhahn; Paulus G Schurr; Rudolf Erttmann; Melitta Schachner; Dietrich Kluth; Guido Sauter; Jakob R Izbicki
Journal:  Ann Surg Oncol       Date:  2007-10-05       Impact factor: 5.344

Review 6.  L1 cell adhesion molecules as regulators of tumor cell invasiveness.

Authors:  Priscila F Siesser; Patricia F Maness
Journal:  Cell Adh Migr       Date:  2009-07-07       Impact factor: 3.405

7.  Universal expression of cell adhesion molecule NCAM in neuroblastoma in contrast to L1: implications for different roles in tumor biology of neuroblastoma?

Authors:  Robin Wachowiak; Tamina Rawnaq; Roman Metzger; Alexander Quaas; Henning Fiegel; Nils Kähler; Udo Rolle; Jakob R Izbicki; Jussuf Kaifi; Holger Till
Journal:  Pediatr Surg Int       Date:  2008-12       Impact factor: 1.827

8.  Decreased anxiety, altered place learning, and increased CA1 basal excitatory synaptic transmission in mice with conditional ablation of the neural cell adhesion molecule L1.

Authors:  Janice W S Law; Alan Y W Lee; Mu Sun; Alexander G Nikonenko; Sookja K Chung; Alexander Dityatev; Melitta Schachner; Fabio Morellini
Journal:  J Neurosci       Date:  2003-11-12       Impact factor: 6.167

9.  Increased survival of children with solid tumours: how did we get there and how to keep the success going?

Authors:  Catherine Rechnitzer
Journal:  Cancer Imaging       Date:  2011-10-03       Impact factor: 3.909

Review 10.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

View more
  4 in total

1.  Small-molecule inhibitors of FGFR, integrins and FAK selectively decrease L1CAM-stimulated glioblastoma cell motility and proliferation.

Authors:  Hannah J Anderson; Deni S Galileo
Journal:  Cell Oncol (Dordr)       Date:  2016-02-16       Impact factor: 6.730

Review 2.  Glioblastoma: molecular pathways, stem cells and therapeutic targets.

Authors:  Meena Jhanwar-Uniyal; Michael Labagnara; Marissa Friedman; Amanda Kwasnicki; Raj Murali
Journal:  Cancers (Basel)       Date:  2015-03-25       Impact factor: 6.639

3.  Tumorigenic proteins upregulated in the MYCN-amplified IMR-32 human neuroblastoma cells promote proliferation and migration.

Authors:  Hayat Zaatiti; Jad Abdallah; Zeina Nasr; George Khazen; Anthony Sandler; Tamara J Abou-Antoun
Journal:  Int J Oncol       Date:  2018-01-04       Impact factor: 5.650

4.  Increased L1CAM (CD171) levels are associated with glioblastoma and metastatic brain tumors.

Authors:  Robin Wachowiak; Matthias Krause; Steffi Mayer; Nicole Peukert; Anne Suttkus; Wolf C Müller; Martin Lacher; Jürgen Meixensberger; Ulf Nestler
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.